| ¿µ¹® | peripheral nerve | ÇÑ±Û | ¸»ÃʽŰæ |
|---|---|---|---|
| ¼³¸í | ÁßÃ߽Űæ°è¸¦ Á¦¿ÜÇÑ ³ª¸ÓÁö ¸ðµç½Å°æÀ» ¸»ÇÔ. ÁßÃ߽Űæ°è´Â ³ú¿Í ô¼ö¸¦ ¸»Çϸç, ±×¿Ü ³ª¸ÓÁö ½Å°æµé·Î½á ½ÇÁ¦ÀûÀ¸·Î °¢ ±â°üÀ̳ª »çÁö ¸»´Ü¿¡ ½Å°æÀÌ ºÐÆ÷Çϸç, ÀÚ±ØÀ» Àü´ÞÇÏ´Â ÀÏÀ» ÇÏ´Â ½Å°æÀ» ¸ðµÎ ÅëÆ²¾î ¸»ÃʽŰæÀ̶ó ÇÑ´Ù. ³ú¿¡¼ ¹Ù·Î ³ª¿Í ºÐÆ÷ÇÏ´Â ³ú½Å°æ°ú ô¼ö¿¡¼ ±â½ÃÇϴ ô¼ö½Å°æµµ ¸ðµÎ ¸»ÃʽŰ濡 ÇØ´çÇÑ´Ù. ¶ÇÇÑ ¸»ÃʽŰ濡´Â °¢Á¾ ÀÚÀ²½Å°æÀ» ´ã´çÇÏ´Â ±³°¨½Å°æ, ºÎ±³°¨½Å°æµµ Æ÷ÇԵȴÙ. |
||
| ¿µ¹® | neurofibromatosis | ÇÑ±Û | ½Å°æ¼¶À¯Á¾Áõ |
|---|---|---|---|
| ¼³¸í | Àü½ÅÀÇ ¿©·¯°÷¿¡ ¹«´õ±â·Î ³ª´Â ½Å°æ¼¶À¯Á¾À» Ư¡À¸·Î ÇÏ´Â À¯Àü¼º Àü½Å º´. ¸»ÃÊ ½Å°æ»Ó ¾Æ´Ï¶ó ÁßÃß ½Å°æ°èµµ ħ¹üÇÒ ¼ö ÀÖ´Ù. ½Å°æ¼¶À¯Á¾Àº ÁÖ·Î Àü½ÅÀÇ ÇǺο¡ ¹ß»ýµÇÁö¸¸ ½Å°æ¾ó±â ȤÀº ³»Àå¿¡ »ý±â´Â ¼öµµ ÀÖ´Ù. ÇǺο¡´Â ¶ÇÇÑ °÷°÷¿¡ ƯÀ¯ÀÇ °¥»ö»ö¼Ò¹ÝÀ» º¸°Ô µÈ´Ù. °ñ°ÝÀÇ º¯ÇüÀ» ÀÏÀ¸Å³ ¼öµµ ÀÖ´Ù. ½Å°æÃÊÁ¾À̳ª ¾Ç¼º½Å°æÃÊÁ¾, ´õ¿íÀÌ ½Å°æ±³Á¾À̳ª ¼ö¸·Á¾ µîÀÇ µÎ°³³»Á¾¾çÀ» ÇÕº´ÇÔµµ ¾Ë·ÁÁ® ÀÖ´Ù. 1Çü(von Recklinghausen º´, ÀüÇüÀû ½Å°æ¼¶À¯Á¾Áõ)°ú 2Çü(ÁßÃßÇü ¶Ç´Â û°¢½Å°æ¼¶À¯Á¾Áõ)À¸·Î ±¸ºÐÇÑ´Ù. ÀüÇüÀû ½Å°æ¼¶À¯Á¾Áõ(1Çü)ÀÌ °¡Àå ¸¹ÀÌ ¹ß»ýÇÏ¸ç ´ÙÀ½°ú °°Àº 3°¡Áö ¼Ò°ßÀ» º¸Àδô. Áï ¨ç üǥ¸é, ü³» ¿©·¯ °÷¿¡ »êÀçµÇ¾î ¹ß»ýÇÏ´Â ¾ó±â¸ð¾ç½Å°æÁ¾, ¨è ¿ìÀ¯Ä¿ÇǹÝÁ¡, ¨é ¸®½¬(Lisch) °áÀý·Î ºÒ¸®´Â ȫäÀÇ Âø»ö°ú¿ÀÁ¾ÀÌ´Ù. 2ÇüÀº 1Çüº¸´Ù ¹ß»ýºóµµ°¡ Àû°í, Ư¡ÀûÀ¸·Î ¾çÂʼº û°¢½Å°æÁ¾ÀÌ ÀÖÀ¸¸ç, ¿ìÀ¯¹ÝÁ¡Àº º¸À̳ª ¸®½¬°áÀýÀº ¾ø´Ù. |
||
| PV | pancreatic vein; papillomavirus; paraventricular; paravertebral; pemphigus vulgaris; peripheral vasc... |
|---|---|
| NF | nafcillin; National Formulary; nephritic factor; neurofibromatosis; neurofilament; neutral fraction;... |
| NF1 | neurofibromatosis type I; nuclear factor 1 |
| NF2 | neurofibromatosis type II |
| NFNS | neurofibromatosis-Noonan syndrome |
| NF1 | NEUROFIBROMATOSIS TYPE 1 |
|---|---|
| NF | Neurofibromatosis |
| NF 1 | Neurofibromatosis |
| NF 1 | Neurofibromatosis 1 |
| NF 2 | Neurofibromatosis 2 |
| abortive neurofibromatosis | incomplete neurofibromatosis |
|---|---|
| genes, neurofibromatosis 1 | Tumour suppressor genes located on the long arm of human chromosome 17 in the region 17q11.2. Mutation of these genes is thought to cause neurofibromatosis 1. (12 Dec 1998) |
| genes, neurofibromatosis 2 | Tumour suppressor genes located on the long arm of human chromosome 22. Mutation or loss of these genes causes neurofibromatosis 2. (12 Dec 1998) |
| central type neurofibromatosis | Type I neurofibromatosis. Incomplete neurofibromatosis, multiple neurofibromas with minimal manifestations, perhaps limited to cafe-au-lait spots; individuals with minimal lesions may have offspring with severe involvement. Synonym: abortive neurofibromatosis. (05 Mar 2000) |
| neurofibromatosis | <oncology> One of the most common disorders in genetics, neurofibromatosis encompasses at least two diseases, designated NF-1 and NF-2. NF-1 or classic neurofibromatosis, is characterised by the familiar cafe- au-lait spots, axillary freckling, cutaneous and visceral neurofibromas (which sometimes undergo malignant transformation), gliomas, scoliosis, and Lisch nodules of the iris. NF-1 is associated with the the von Recklinghausen Neurofibromatosis locus that encodes the NF-1 protein, a GTPase activating protein which interacts with the ras proteins. The gene is located on chromosome 17. NF-2, also called acoustic or central neurofibromatosis, features neurofibromas restricted to the acoustic nerve (usually bilateral) and the central nervous system, skin lesions may or may not be present. The gene is located on chromosome 22. There are no biochemical markers of the disorder, but the cloning of both the NF-1 and NF-2 genes makes DNA-based diagnosis possible in some families. Both genes appear to be tumour suppressor genes. Both conditions are autosomal dominant, but the variable penetrance and expressivity and high frequency of new mutations make genetic counseling difficult. Inheritance: autosomal dominant. (29 Dec 1997) |
| neurofibromatosis 1 | A congenital autosomal dominant disorder characterised by developmental changes in the nervous system, muscles, bones, and skin especially in those derived from the embryonic neural crest. There are multiple cutaneous tumours and tumours of the peripheral and central nervous system. The disease has been linked to mutations of the nf1 gene on chromosome 17. (12 Dec 1998) |
| neurofibromatosis 2 | Severe autosomal dominant disorder characterised especially by bilateral acoustic neuromas as well as other multiple tumours including meningiomas, ependymomas, spinal neurofibromas, and gliomas. The disease has been linked to mutations of the nf2 gene on chromosome 22. (12 Dec 1998) |
| catheterization, peripheral | Insertion of a catheter into a peripheral artery, vein, or airway for diagnostic or therapeutic purposes. (12 Dec 1998) |
| peripheral | <anatomy> Pertaining to or situated at or near the periphery, situated away from a centre or central structure. (18 Nov 1997) |
| peripheral aneurysm | A saclike aneurysm springing from one side of an artery, an aneurysm of one of the smaller branches of an artery. (05 Mar 2000) |
| peripheral anterior synechia | Adhesion of the iris to the posterior surface of the cornea in the angle of the anterior chamber; associated with angle-closure glaucoma. Synonym: peripheral anterior synechia. Origin: G. Gonia, angle, + synechis, holding together (05 Mar 2000) |
| peripheral arteriosclerosis | Arteriosclerosis in any of the vessels beyond the aorta; most often refers to the lower extremities. (05 Mar 2000) |
| peripheral blood stem cell transplantation | A procedure that is similar to bone marrow transplantation. Doctors remove healthy immature cells (stem cells) from a patient's blood and store them before the patient receives high-dose chemotherapy and possibly radiation therapy to destroy the leukaemia cells. The stem cells are then returned to the patient, where they can produce new blood cells to replace cells destroyed by the treatment. (12 Dec 1998) |
| peripheral cataract | A cataract in which the opacity affects the cortex of the lens. Synonym: peripheral cataract. (05 Mar 2000) |
| peripheral chemoreceptor | The chemoreceptor's in the carotid and aortic bodies that are stimulated by chemical changes in the composition of the blood such as hypoxia. (05 Mar 2000) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|